FindTrial
Sign In

A comparision of oral Tramadol and oral Tapentadol for prevention of perioperative shivering during subarachnoid block in patients undergoing Transurethral Resection of Prostate-A Randomized control trial

A comparision of oral Tramadol and oral Tapentadol for prevention of perioperative shivering during subarachnoid block in patients undergoing Transurethral Resection of Prostate-A Randomized control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055415
Enrollment
150
Registered
2023-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: oral tramadol: oral tramadol 50mg with sips of water 90minutes prior to surgery. Control Intervention1: oral tapentadol: oral tapentadol 50mg with sips of water 90minutes prior to surge

Sponsors

Namratha M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Status 1,2,3 Age between 50-60 years Patients undergoing Transurethral Resection of the Prostate under subarachnoid block

Exclusion criteria

Exclusion criteria: ASA IV Patient refusal or who are unable to give consent. Coagulopathy Infection at the injection site Allergy to local anesthetic

Design outcomes

Primary

MeasureTime frame
To compare oral Tramadol and oral Tapentadol as a premedicant to prevent perioperative shivering following subarachnoid block in patients undergoing Transurethral Resection of Prostate. Timepoint: 5 minutes prior to subarachnoid until 90 minutes of surgery—

Secondary

MeasureTime frame
To compare oral Tramadol and oral Tapentadol as a premedicant to prevent perioperative shivering following subarachnoid block in patients undergoing Transurethral Resection of Prostate. Timepoint: 5 minutes prior to subarachnoid until 90 minutes of surgery—

Countries

India

Contacts

Public ContactNamratha M

KAHERs Jawaharlal Nehru Medical College

drvinayakjannu84@gmail.com9743908033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026